Patent Assignment
Reel/Frame 028347/0389
Assignment of Assignor's Interest
Recorded: 2012-06-08
Pages: 9
Assignor
ARYX THERAPEUTICS
Executed: 2007-10-22
Assignee
ARYX THERAPEUTICS, INC.
6300 DUMBARTON CIRCLE, FREMONT, CALIFORNIA, 94555
Covered Properties
(3)
Materials and Methods for Treating Coagulation Disorders
Haloalkyl Ester Derivatives of Coumarin for the Treatment of Coagulation Disorders
Halogenated Ester Derivatives of Coumarins for the Treatment of Coagulation Disorders
Related Assignments
(9)
Other recorded transfers of the patents in this record — the chain of ownership.
Corrective Assignment to Correct the Name of the Assignee Which Should Be Aryx Therapeutics Previously Recorded on Reel 022529 Frame 0584. Assignor(S) Hereby Confirms the Name of the Assignee to Be Aryx Therapeutics and Not Aryx Therapeutics, Inc..
Jun 6, 2012
From: DRUZGALA, PASCAL; BECKER, CYRUS
To: ARYX THERAPEUTICS
Reel/Frame 028332/0196 →
Corrective Assignment to Correct the Name of the Assignee Which Should Be Aryx Therapeutics Previously Recorded on Reel 023164 Frame 0155. Assignor(S) Hereby Confirms the Name of the Assignee Should Be Aryx Therapeutics and Not Aryx Therapeutics, Inc..
Jun 6, 2012
From: DRUZGALA, PASCAL; BECKER, CYRUS
To: ARYX THERAPEUTICS
Reel/Frame 028332/0203 →
Corrective Assignment to Correct the Name of the Assignee Which Should Be Aryx Therapeutics Previously Recorded on Reel 023164 Frame 0203. Assignor(S) Hereby Confirms the Name of the Assignee Should Be Aryx Therapeutics and Not Aryx Therapeutics Inc.
Jun 8, 2012
From: DRUZGALA, PASCAL; BECKER, CYRUS
To: ARYX THERAPEUTICS
Reel/Frame 028349/0801 →
Release of Security Interest
Feb 6, 2013
From: AYER CAPITAL PARTNERS MASTER FUND, L.P.; MPM BIOVENTURES III, L.P.; MPM BIOVENTURES III-QP, L.P.; MPM BIOVENTURES III GMBH & CO. BETEILIGUNGS KG
To: ARYX THERAPEUTICS, INC.
Reel/Frame 029767/0524 →
Security Interest
Apr 16, 2019
From: ESPERO BIOPHARMA, INC.
To: HORIZON TECHNOLOGY FINANCE CORPORATION
Reel/Frame 048918/0544 →
Change of Name
Jul 23, 2020
From: ARMETHEON, INC.
To: ESPERO BIOPHARMA, INC.
Reel/Frame 053293/0930 →
Assignment of Assignor's Interest
Oct 23, 2020
From: ESPERO BIOPHARMA, INC.
To: HESP LLC
Reel/Frame 054150/0011 →
Assignment of Assignor's Interest
May 4, 2022
From: HESP LLC
To: CADRENAL THERAPEUTICS
Reel/Frame 059811/0221 →
Release of Security Interest
Oct 4, 2022
From: HORIZON TECHNOLOGY FINANCE CORPORATION
To: ESPERO BIOPHARMA, INC.
Reel/Frame 061299/0927 →